These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 2993752)
1. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme]. Roques BP J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752 [TBL] [Abstract][Full Text] [Related]
2. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550 [TBL] [Abstract][Full Text] [Related]
3. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo. Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620 [TBL] [Abstract][Full Text] [Related]
4. Degradation of exogenous enkephalin in the guinea-pig ileum: relative importance of aminopeptidase, enkephalinase and angiotensin converting enzyme activity. Geary LE; Wiley KS; Scott WL; Cohen ML J Pharmacol Exp Ther; 1982 Apr; 221(1):104-11. PubMed ID: 6278132 [No Abstract] [Full Text] [Related]
5. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition. Chérot P; Devin J; Fournié-Zaluski MC; Roques BP Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase A. Chipkin RE; Iorio LC; Barnett A; Berger J; Billard W Adv Biochem Psychopharmacol; 1982; 33():235-42. PubMed ID: 6751031 [No Abstract] [Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain. Norman JA; Autry WL; Barbaz BS Mol Pharmacol; 1985 Dec; 28(6):521-6. PubMed ID: 3001497 [TBL] [Abstract][Full Text] [Related]
9. Enkephalinase inhibition by thiorphan and subsequent response of ethanol, normorphine and enkephalins on mouse vas deferens. Blum K; Wallace JE; DeLallo L; Briggs AH Funct Neurol; 1986; 1(2):156-64. PubMed ID: 3301556 [TBL] [Abstract][Full Text] [Related]
10. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra. Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779 [TBL] [Abstract][Full Text] [Related]
12. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492 [TBL] [Abstract][Full Text] [Related]
13. Peptidases involved in the inactivation of exogenous and endogenous enkephalins. Schwartz JC; de la Baume S; Yi CC; Chaillet P; Marcais-Collado H; Costentin J J Neural Transm Suppl; 1983; 18():235-43. PubMed ID: 6348211 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility). Nabeshima T; Katoh A; Kameyama T J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094 [TBL] [Abstract][Full Text] [Related]
15. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan. Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695 [TBL] [Abstract][Full Text] [Related]
16. [New approach in the research of analgesics and antihypertensive agents]. Roques BP Ann Pharm Fr; 1991; 49(6):317-26. PubMed ID: 1842170 [TBL] [Abstract][Full Text] [Related]
17. The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum. Aoki K; Kajiwara M; Oka T Jpn J Pharmacol; 1984 Sep; 36(1):59-65. PubMed ID: 6094902 [TBL] [Abstract][Full Text] [Related]
18. Characterization of enkephalin degradation in rat plasma. Weinberger SB; Zafuto CE; Walker RC; Martinez JL NIDA Res Monogr; 1986; 75():263-6. PubMed ID: 3123942 [TBL] [Abstract][Full Text] [Related]
19. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties. Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541 [TBL] [Abstract][Full Text] [Related]